Erlotinib TabletsErlotinib tablets, such as ERLONAT 150mg and ERLEVA 150mg, are vital in treating non-small cell lung cancer (NSCLC) and pancreatic cancer. As a tyrosine kinase inhibitor, erlotinib targets EGFR mutations, inhibiting cancer cell growth and spread. Its usage benefits patients by extending survival rates, improving symptoms, and enhancing quality of life. Effects include reduced tumor size, improved breathing, and increased energy levels. However, side-effects like rash, diarrhea, and fatigue may occur. Despite potential adverse reactions, Erlotinib tablets represent a significant advancement in targeted cancer therapy, offering hope and efficacy for patients with NSCLC and pancreatic cancer.
|
|
MODERN TIMES HELP LINES PHARMA
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |